Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Symptoms According to the Level of Diagnostic and Therapeutic Intervention in Patients Hospitalized in a Palliative Care Unit

NCT07926841 is registered in ClinicalTrials.gov with Consorci Sanitari de l'Alt Penedès i Garraf as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07926841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Symptoms According to the Level of Diagnostic and Therapeutic Intervention in Patients Hospitalized in a Palliative Care Unit
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Phase
Observational
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
June 30, 2028
Enrollment
265 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, palliative care

Arms

As registered; 1 arm.

  • Patients admitted to the palliative care unit

    Consecutive adult patients with an underlying cancer admitted to the Palliative Care Unit of Hospital Residencia Sant Camil during the study period.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Symptom burden (total ESAS score) by NADT group Within 72 hours of admission to the palliative care unit

    Total score of the Edmonton Symptom Assessment System (ESAS), calculated as the sum of the intensity scores of 9 symptoms, each rated from 0 (absent) to 10 (worst imaginable). Total score range: 0 to 90; higher scores indicate greater symptom burden. Reported as mean with 95% CI for each NADT group.

Lead sponsor's other trials

Consorci Sanitari de l'Alt Penedès i Garraf, most recent start first.

Similar trials

Same condition (Neoplasms) and phase, most recent start first.